Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Trial details
- Registry ID
- NCT07495852
- Drugs studied
- Gen 2 Travoprost Intracameral Implant, Sham Procedure, Timolol eye drops 0.5%
TrialRedline tracks 16 clinical trials sponsored by Glaukos Corporation: 5 Phase 3, 11 Phase 2.
Company identity has not yet been verified
Names as written in the registry records.
NCT07075718 · Glaukos Corporation
Before: 610 participants (planned). After: 110 participants (planned).
Before: PHASE2, PHASE3. After: PHASE2.